Geode Capital Management, LLC Fusion Pharmaceuticals Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$7.9 - $21.32 $20,231 - $54,600	2,561 Added 6.51%	41,907 $893,000
Q4 2023 Feb 13, 2024	BUY	$2.48 - $9.65 $21,025 - $81,812	8,478 Added 27.47%	39,346 $378,000
Q3 2023 Nov 13, 2023	BUY	$2.37 - $4.63 $1,170 - $2,287	494 Added 1.63%	30,868 $80,000
Q2 2023 Aug 11, 2023	BUY	$3.47 - $5.33 $18,175 - $27,918	5,238 Added 20.84%	30,374 $141,000
Q3 2021 Nov 12, 2021	BUY	$7.83 - $9.41 $16,028 - $19,262	2,047 Added 8.87%	25,136 $199,000
Q3 2020 Nov 13, 2020	BUY	$11.8 - $17.1 $272,450 - $394,821	23,089 New	23,089 $277,000

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.